Skip to main content
. 2018 Sep 6;2018:9432606. doi: 10.1155/2018/9432606

Table 2.

Residual tumor and upstaging results after repeat TURBT in patients.

Non referred group 
(N=220)
Referred group 
(N=69)
P value
Ta at initial TURBT

Number of patients 33 15

Residual tumor 19(57.6%) 10 (66.7%) 0.210

Overall upstaging 4 (12.1%) 4 (26.7%) 0.551

Upstaging to T2 1 (3.0%) 0 (0%) 0.496

No residual tumor 14 (42.4%) 5 (33.3%) 0.210

T1 at initial TURBT

No. of patients 187 54

Residual tumor 104 (55.6%) 47 (87.0%) <0.001

Overall upstaging 6 (3.2%) 11 (20.4%) <0.001

Upstaging to T2 6 (3.2%) 11 (20.4%) <0.001

No residual tumor 83 (44.4%) 7 (13.0%) <0.001

Overall

No. of patients 220 69

Residual tumor 123 (55.9%) 57 (82.6%) <0.001

Overall upstaging 10(4.5%) 15 (21.7%) <0.001

Upstaging to T2 7 (3.2%) 11 (15.9%) <0.001

No residual tumor 97 (44.1%) 12 (17.3%) <0.001

TURBT: transurethral resection of bladder tumor.